It specifically blocks the interaction site of RAC1 with its GEFs, particularly RAC1-TIAM1 and RAC1-DOCK180, and it was reported to induce apoptosis and inhibit proliferation and migration in LN229 and U-87 glioma cell lines [13]. The gene discussed is RAC1; the disease is central nervous system cancer.